MARKET

CNTB

CNTB

Connect Biopharma Holdings Ltd
NASDAQ
2.260
-0.250
-9.96%
After Hours: 2.339 +0.079 +3.50% 16:00 07/13 EDT
OPEN
2.490
PREV CLOSE
2.510
HIGH
2.490
LOW
2.230
VOLUME
481.50K
TURNOVER
--
52 WEEK HIGH
3.820
52 WEEK LOW
1.050
MARKET CAP
142.30M
P/E (TTM)
-1.9589
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CNTB last week (0706-0710)?
Weekly Report · 19h ago
Top Biotech Gainers: VRAX Jumps 100% After Fosun Deal, FBRX Soars On Vitiligo Data, TRAX On Watch
NASDAQ · 4d ago
Connect Biopharma Holdings (CNTB) Receives a New Rating from Oppenheimer
TipRanks · 4d ago
Connect Biopharma Price Target Announced at $8.00/Share by Oppenheimer
Dow Jones · 4d ago
Oppenheimer Initiates Coverage On Connect Biopharma Hldgs with Outperform Rating, Announces Price Target of $8
Benzinga · 4d ago
CONNECT BIOPHARMA HOLDINGS LTD <CNTB.O>: OPPENHEIMER INITIATES COVERAGE WITH OUTPERFORM RATING; TARGET PRICE $8
Reuters · 4d ago
Connect Biopharma initiated with an Outperform at Oppenheimer
TipRanks · 4d ago
Weekly Report: what happened at CNTB last week (0629-0703)?
Weekly Report · 07/06 10:34
More
About CNTB
Connect Biopharma Holdings Limited is a global clinical-stage biopharmaceutical company. The Company is focused on advancing rademikibart, a potentially best-in-class next generation anti-interleukin-4-receptor alpha (IL-4Rα) antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease (COPD). Its lead product candidate, rademikibart, is an antibody designed to target interleukin-4 receptor alpha (IL-4Rα) in development for the treatment of atopic dermatitis (AD) and asthma. As an inhibitor of IL-4Rα, rademikibart blocks inflammatory signaling by both IL-4 and IL-13. The Company has completed a global Phase II trial (CBP-201-WW001) of rademikibart in adult patients with moderate-to-severe AD.

Webull offers Connect Biopharma Holdings Ltd (ADR) stock information, including NASDAQ: CNTB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CNTB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CNTB stock methods without spending real money on the virtual paper trading platform.